Harmony Biosciences to Participate in 2026 Cantor Global Healthcare Conference Life Science Investing
CytomX Therapeutics Announces FDA Fast Track Designation for Varsetatug masetecan for Relapsed/Refractory Metastatic Colorectal Cancer Life Science Investing
Corvus Pharmaceuticals Announces Publication in Blood of Final Phase 1 Data from the Soquelitinib Phase 1/1b T Cell Lymphoma Trial Life Science Investing
AbbVie Submits Regulatory Application to EMA for SKYRIZI® Subcutaneous Induction for Adults with Moderately to Severely Active Crohn's Disease Pharmaceutical Investing
